[1]CALO V, MIGLIAVACCA M, BAZAN V, et al. STAT proteins: from normal control of cellular events to tumorigenesis [J]. J Cell Physiol, 2003, 197(2):157-168.
[2]LANNING N J, CARTER-SU C. Recent advances in growth hormone signaling [J]. Rev Endocr Metab Disorders, 2006, 7(4):225-235.
[3]HERRINGTON J, SMIT L S, SCHWARTZ J, et al. The role of STAT proteins in growth hormone signaling [J]. Oncogene, 2000, 19(21):2585-2597.
[4]BUETTNER R, MORA L B, JOVE R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention [J]. Clin Cancer Res, 2002, 8(4):945-954.
[5]HIRANO T, ISHIHARA K, HIBI M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors [J]. Oncogene, 2000, 19(21):2548-2556.
[6]MOLENAAR A, WHEELER T, MCCRACKEN J, et al. The STAT3-encoding gene resides within the 40 kbp gap between the STAT5A-and STAT5B-encoding genes in cattle [J]. Anim Genet, 2000, 31(5):339.
[7]MEYER L, BROCKMANN G, SCHWERIN M, et al. A highly polymorphic GT-repeat in the bovine STAT5B encoding gene on BTA19 [J]. Anim Genet, 1999, 30(1):72-73.
[8]BILD A H, TURKSON J, JOVE R. Cytoplasmic transport of Stat3 by receptor-mediated endocytosis [J]. The EMBO J, 2002, 21(13):3255-3263.
[9]XU D, QU C K. Protein tyrosine phosphatases in the JAK/STAT pathway [J]. Front Biosci J Virt Lib, 2008, 13: 4925-4932.
[10]CROKER B A, KIU H, NICHOLSON S E. SOCS regulation of the JAK/STAT signalling pathway [J]. Semi Cell Dev Biol, 2008, 19: 414-422.
[11]SHUAI K. Regulation of cytokine signaling pathways by PIAS proteins [J]. Cell Res, 2006, 16(2):196-202.
[12]AKIRA S. IL-6-regulated transcription factors [J]. Int J Biochem Cell Biol, 1997, 29(12):1401-1418.
[13]WJST M, LICHTNER P, MEITINGER T, et al. STAT3 single-nucleotide polymorphisms and STAT3 mutations associated with hyper-IgE syndrome are not responsible for increased serum IgE serum levels in asthma families [J]. Eu J Hum Genet, 2008, 17(3):352-356.
[14]HOLLAND S M, DELEO F R, ELLOUMI H Z, et al. STAT3 mutations in the hyper-IgE syndrome [J]. New Eng J Med, 2007, 357(16):1608-1619.
[15]LITONJUA A A, TANTISIRA K G, LAKE S, et al. Polymorphisms in signal transducer and activator of transcription 3 and lung function in asthma [J]. Respir Res, 2005, 6: 52.
[16]ZHONG Y, FENG J, CHEN B, et al. Signal transducer and activator of transcription 3 (STAT3) gene polymorphisms are associated with treatment outcomes in acute myeloid leukemia [J]. Int J Lab Hematol, 2012, 34(4):383-389.
[17]NAIR R R, TOLENTINO J H, HAZLEHURST L A. Role of STAT3 in Transformation and Drug Resistance in CML [J]. Front Oncol, 2012, 2: 30.
[18]TAMURA G, YIN J, WANG S, et al. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas [J]. J Natl Cancer Ins, 2000, 92(7):569-573.
[19]DARNELL JR J E. STATs and gene regulation [J]. Science, 1997, 277(5332):1630-1635.
[20]KIU H, NICHOLSON S. Biology and significance of the JAK/STAT signalling pathways [J]. Growth Factors, 2012, 30(2):88-106.
[21]SEITA J, ASAKAWA M, OOEHARA J, et al. Interleukin-27 directly induces differentiation in hematopoietic stem cells [J]. Blood, 2008, 111(4):1903-1912.
[22]HANKEY P. Regulation of hematopoietic cell development and function by Stat3 [J]. Front Biosci, 2009, 14(1):5273-5290.
[23]KHATIB H, HUANG W, MIKHEIL D, et al. Effects of signal transducer and activator of transcription (STAT) genes STAT1 and STAT3 genotypic combinations on fertilization and embryonic survival rates in Holstein cattle [J]. J Dairy Sci, 2009, 92(12):6186-6191. |